Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GraCiAH: G-CSF in Severe Alcoholic Hepatitis
NCT02442180Phase 3Terminated
- Sponsor
- Hallym University Chuncheon Sacred Heart Hospital
- Start
- Jul 2015
- Primary completion
- Jul 2022
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of filgrastim in alcoholic hepatitis (AH), sponsored by Hallym University Chuncheon Sacred Heart Hospital. Started Jul 2015; status: terminated.
02
Drugs
filgrastim
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT02442180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02442180.